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esponsibility of Xi’Abstract A rapid, novel spectroﬂuorimetric method to determine epristeride (EP) in biological ﬂuids
and a pharmaceutical formulation was developed, based on the fact that ﬂuorescence intensity of
L-tryptophan could be quenched by EP in the medium of pH¼9.0. The various factors inﬂuencing
ﬂuorescence quenching were discussed. The quenching mechanism was investigated with the quenching
type, synchronous ﬂuorescence spectra and quantum efﬁciency. Under the optimized conditions,
ﬂuorescence quenching value (ΔF¼FL-tryptophan−FEP–L-tryptophan) showed a good linear relationship with
the EP concentration ranging from 0.4 to 12.0 μg/mL. The linearity, recovery and limit of detection
demonstrated that the proposed method was suitable for EP determination in biological ﬂuids and EP
tablets. The method was successfully applied to the analysis of EP in real samples and the obtained results
were in good agreement with the results of the ofﬁcial method.
& 2013 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Benign prostatic hyperplasia is a disease of older men, and over
50% of men above 50 years have been found at autopsy, to have
histological evidence of prostatic enlargement. Epristeride [17sity. Production and hosting by Elsev
1
4 7975244.
an Jiaotong University.β-(N-tert.-butyl carboxamido)-androst-3,5-diene-3- carboxylic acid]
(EP), a 5α-reductase inhibitor (Fig. 1), through inhibiting the activity
of 5α-reductase in the human body, can restrain testosterone from
being reduced to dihydrotestosterone, so as to lower the concentration
of dihydrotesterone and thus treat benign prostate hyperplasia [1].
Epristeride is the second inhibitor of 5α-reductase following ﬁnasteride
for the treatment of benign prostate hyperplasia. Finasteride is the
competitive inhibitor of 5α-reductase while epristeride is a non-
competitive one and has a more rapid clinical onset than ﬁnasteride
[2]. Therefore, epristeride has a broader prospect of application, and an
analytical procedure is needed for quality assurance on pharmaceutical
preparations.
Literature survey reveals several methods for the determination of
EP in serum or EP tablets with high-performance liquidier B.V. All rights reserved.
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Fig. 1 The structure of epristeride.
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involve a complex procedure and costly solvents and produce a lot of
waste liquid. Compared with chromatography, spectroﬂuorimetry
attracts more and more interest with its high sensitivity and simplicity,
and thus has been used extensively in the analysis of drugs and food
[5–7]. In our previous publication, the interaction of EP and bovine
serum albumin with ﬂuorescence quenching method and determined
EP in EP tablet and human serum were developed, but the limit of
detection was relatively high (0.28 μg/mL) [8].
Tryptophan consists of D-tryptophan and L-tryptophan. D-tryptophan
is hardly utilized by organisms [9]. L-tryptophan is one of the necessary
amino acids for life activities of creatures and is widely applied in
medicine, food and feedstuff. Investigating the interaction of drugs and
L-tryptophan is signiﬁcant for knowing the transport and distribution of
drugs in body in order to clarify the action mechanism and
pharmaceutical dynamics of drugs. For example, the interaction of
L-tryptophan and p-hydroxyphenylpyruvic acid or penicillin G with
ﬂuorescence quenching method was studied [10,11]. In our previous
publication, the interaction of tropisetron hydrochloride and L-trypto-
phan was considered [12].
In this paper, the interaction of EP and L-tryptophan was studied
with spectroﬂuorimetry. It was found that the native ﬂuorescence
intensity of L-tryptophan was distinctly quenched by EP. Under
experimental conditions, the ﬂuorescence quenching degree of
L-tryptophan (ΔF) had a linear relationship with the concentration of
EP. Hence, a new spectroﬂuorimetry was developed to determine EP
with a relatively low detection limit. The proposed method was
successfully applied to determine EP in real samples and the obtained
results were in good agreement with that of the ofﬁcial method
(titration method) [13]. The mechanism of action was also formulated.2. Experimental
2.1. Apparatus and chemicals
A Hitachi F-4500 spectroﬂuorimeter (Japan) was used for all the
ﬂuorescence measurement, with excitation slits at 2.5 nm and
emission slits at 5.0 nm, λex¼281 nm and 1-cm quartz cell. The
pH measurements were carried out with a pHS-25B pH-meter
(Shanghai, China). All absorption spectral recordings and absor-
bance measurements were performed on a UV 2501 spectro-
photometer (Shimadzu, Japan).
Epristeride standard and epristeride tablets (Batch number:
20120101, Labeled value: 5 mg/tablet) were kindly provided
by Jiangsu Lianhuan pharmaceutical Co., Ltd., Jiangsu, China.
L-tryptophan and other materials were of analytical grade and
purchased from Sinopharm Chemical Reagent Co., Ltd., Shanghai,
China. Double distilled water was used throughout.An epristeride standard solution of 1.00 mg/mL was prepared
by dissolving 0.0500 g of epristeride in 50 mL of anhydrous
ethanol and kept in a cool and a dark place.
A standard L-tryptophan solution of 1.00 mg/mL was prepared
by dissolving 0.0500 g of L-tryptophan in 50 mL of 0.1 M NaOH
aqueous solution and kept in a cool and a dark place.
The buffer solution of ammonia–ammonium chloride (0.1 M,
pH 9.0) was employed to control the pH of the sample solutions.
2.2. Sample preparation
2.2.1. Epristeride tablets treatment
Ten tablets of epristeride were weighed and crushed, and then
sample powder of about ﬁve tablets was accurately weighed and
placed in a 50 mL of beaker and dissolved with anhydrous ethanol.
Insoluble excipient was removed by ﬁltration through a 0.45 μm
membrane ﬁlter. The ﬁltered solution was diluted to 50 mL with
anhydrous ethanol.
2.2.2. Urine and serum treatment [5]
First, the urine and the serum samples of healthy volunteers were
collected from local hospitals and stored in polyethylene bottles
after the dilution of 10- and 100-fold with double distilled water,
respectively. Then urine or serum was spiked with convenient
amounts of EP stock. The ﬁnal EP concentration was 1.00 mg/mL.
2.3. Fluorescence measurements
In a 25 mL volumetric ﬂask, 0.25 mL 1.00 mg/mL of L-tryptophan
solution, 3.0 mL of NH3–NH4Cl buffer solution (pH¼9.0) and
adequate EP standard or sample solution were added; the solution
was diluted to the mark with distilled water. Then L-tryptophan
ﬂuorescence spectra were recorded in the range of 250–550 nm
upon excitation at 281 nm.
2.4. Determination of relative ﬂuorescence quantum yield
Fluorescence quantum yield of L-tryptophan with or without EP
was measured using 1.0 10−6 g/mL quinine sulfate as a reference
material.
Under the same apparatus conditions, according to the equation
ϕ2¼ (ϕ1A1F2)/(F1A2) [14], the quantum yield of the analyte was
calculated. In brief, ϕ1 and ϕ2 correspond to the standard and
unknown ﬂuorescence quantum yield, and F1 and F2 are the
integral areas of two calibration ﬂuorescence emission curves; A1
and A2 are the absorbance (λabsorbance¼λexcitation) of the standard
and unknown, and ϕ1¼0.55 (25 1C) is known.3. Results and discussion
3.1. Quenching spectra of L-tryptophan with EP
The ﬂuorescence spectra of L-tryptophan were recorded before and
after incubation with a series concentration of EP in pH¼9.0 at
λex¼281 nm (Fig. 2). It can be seen from Fig. 2 that (1) the
ﬂuorescence intensity of L-tryptophan decreased gradually with the
increase of EP concentration without changing the emission
maximum and shape of the peaks (curve 1–curve 9); (2) the
ﬂuorescence intensity of L-tryptophan was almost completely
quenched when the concentration of EP was up to 200.0 μg/mL
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Fig. 2 Fluorescence quenching spectra of L-tryptophan in the
presence of EP. cL-tryptophan: 10.0 μg/mL; 1–9: cEP is 0.0, 4.0, 8.0,
12.0, 16.0, 40.0, 48.0, 80.0, 200 μg/mL.
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Fig. 3 Effect of concentration of EP on ﬂuorescence quenching in
different concentrations of L-tryptophan.
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the range measured. These results indicated that there was an
interaction between EP and L-tryptophan.
3.2. Effect of L-tryptophan concentration on ﬂuorescence
quenching
The effect of L-tryptophan on ﬂuorescence quenching value
(ΔF¼FL-tryptophan−FEP–L-tryptophan) was investigated. Fig. 3 shows
the effect of concentration of EP on ΔF in different concentrations
of L-tryptophan (curves 1–6). It can be seen that ΔF was enhanced
with increasing L-tryptophan concentration and reached the max-
imum value at 10.0 μg/mL of L-tryptophan and then remained
constant (auxiliary Fig. 3).
The linearity parameters and limit of detection (LOD) of the
proposed method in different concentrations of L-tryptophan are
listed in Table 1. It can be seen from Table 1 that (1) the LOD was
decreased with increasing L-tryptophan concentration and was
similar when the concentration of L-tryptophan was up to 8.0–
12.0 μg/mL; (2) the linear range was narrower in 8.0–12.0 μg/mLof L-tryptophan than in 2.0–6.0 μg/mL of L-tryptophan. To decide
on the concentration of L-tryptophan, the LOD and the linear range
had to be taken into consideration. 10.0 μg/mL of L-tryptophan
was adopted as an optimum concentration for this study.
3.3. Effect of pH on ﬂuorescence quenching
The effect of pH on ﬂuorescence quenching value ΔF¼
FL-tryptophan−FEP–L-tryptophan is shown in Fig. 4. From Fig. 4,
maximum ΔF can be obtained at pH¼9.0. After that, ΔF
decreased with a further increase of pH.
The probable reason is that pH had an important effect on
FL-tryptophan from the results concluded in auxiliary Fig. 4. As
shown in auxiliary Fig. 4, the FL-tryptophan reached a maximum
value at the pH of 9.0 and obviously reduced at higher or lower pH
values. The above results indicated that pH exerts its effect on ΔF
mainly through inﬂuencing the FL-tryptophan.
The effect of buffer solution volume was also studied. Fig. 5 shows
that ΔF changed very little with the buffer solution volume ranging
from 1.0 to 7.0 mL. In this study, a 3.0 mL NH3–NH4Cl buffer
solution (pH¼9.0) was selected as suitable for the optimized method.
3.4. Effect of reaction time on ﬂuorescence quenching
At room temperature, the quenching reaction could reach equili-
brium immediately after EP and L-tryptophan were mixed. The
ﬂuorescence intensity of the mixture varied very little in 2 h.
3.5. Effect of potential interferences
The potential interference of the proposed method was evaluated
by analyzing the standard solution of EP in the presence of tablet
excipients such as lactose, microcrystalline cellulose, sucrose,
magnesium stearate, colloidal silicon dioxide, and other possible
coexisting substances. It was found that the solubility of micro-
crystalline cellulose, croscarmellose sodium, magnesium stearate
or colloidal silicon dioxide was very small under the examination
condition and could be eliminated as sediment from solution.
The effects of other substances were discussed in the determi-
nation of 0.2 mg EP in a 25 mL volumetric ﬂask. The level of
tolerated concentrations of foreign substances was considered as
the maximum concentration found to cause a change in signal, less
than 75%, compared with the signal without foreign substances.
The results are shown in Table 2. The tolerance limits of most
tested substances exceeded the quantity coexisting with the studied
drug EP, suggesting that the method possessed a good selectivity.
3.6. Analytical performance
The calibration graphs for determining EP were obtained under the
experimental conditions described above by plotting L-tryptophan
ﬂuorescence intensity quenching values versus EP concentration in
standard solution, human serum and human urine matrices. The
analytical parameters obtained are given in Table 1.
For comparative studies, the results obtained by this method
were compared with those by other methods for the determination
of EP (Table 3). Venkata et al. [3] and Yan et al. [4] determined
EP with HPLC, in which operation was complicated and con-
sumed a lot of organic reagents and the recovery was not as
satisfactory as expected in spite of lower LOD (0.0025 μg/mL).
Compared with Ref. [8], which also used spectroﬂuorimetry to
Table 1 Linearity parameters and limit of detection of the proposed method in different concentrations of L-tryptophan.
Sample L-tryptophan (μg/mL) The linear range of EP (μg/mL) Linear equation R LOD (μg/mL) [15]
Standard solution 2.0 0.4–16.0 ΔF¼19.98cEP+30.1 0.9952 0.030
4.0 0.4–20.0 ΔF¼26.16cEP+31.8 0.9991 0.022
6.0 0.4–20.0 ΔF¼38.05cEP+92.0 0.9927 0.016
8.0 0.4–12.0 ΔF¼64.25cEP+94.7 0.9937 0.009
10.0 0.4–12.0 ΔF¼76.5cEP+100.5 0.9979 0.008
12.0 0.4–12.0 ΔF¼80.1cEP+107.7 0.9957 0.007
Serum 10.0 0.4–12.0 ΔF¼77.15cEP+116.0 0.9935 0.025
Urine 0.4–12.0 ΔF¼77.82cEP+135.5 0.9942 0.020
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Fig. 4 Effect of pH on ﬂuorescence quenching (cL-tryptophan: 10.0 μg/
mL, cEP: 8.0 μg/mL, curve 1: cL-tryptophan: 10.0 μg/mL).
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Fig. 5 Effect of buffer solution volume on ﬂuorescence quenching
(cL-tryptophan: 10.0 μg/mL, cEP: 8.0 μg/mL).
A.-Q Gong, X.-S. Zhu418determine EP, the detection limit of this work was lower. The
results indicate that this work has advantages such as good
accuracy, high sensitivity, broad linear range as well as simple
and rapid determination.
3.7. Determination of EP in real sample
The method was applied for the determination of EP in commer-
cial tablets. The data are shown in Table 4. The results obtained by
the proposed method (5.02 mg/tablet) were in good agreement
with those obtained by the ofﬁcial method—titration method
(4.99 mg/tablet). The statistical t-test (P¼0.95) was used to
compare the results from both the methods, which showed that
there was no signiﬁcant difference between them.
The method was also applied for determining EP in spiked
human urine and serum (Table 4). Accuracy was assessed with the
recovery of the studied drug. Obtained mean values of the
recoveries ranged from 98.2% to 101.2%, from 104.6% to
107.0%, and from 103.3% to 107.5% for EP tablets, human serum
and human urine respectively; the RSD ranged from 0.38% to
0.58%, from 1.0% to 2.2%, and from 1.5% to 2.0%, respectively,
indicating both good accuracy and precision.
3.8. Discussion of the mechanism of quenching effect
3.8.1. Quenching type
Generally, quenching types of ﬂuorescence often include static and
dynamic quenching. The quenching type is differentiated asfollows:1. The ﬂuorescence quenching spectra of substance
The ﬂuorescence quenching spectra and quenching type
could be analyzed by Stern–Volmer equation:
F0=F ¼ 1þ KsvCQ
Among them, F0 and F are the ﬂuorescence intensities of
L-tryptophan in the absence and presence of EP, respectively;
Ksv is the Stern–Volmer quenching constant; CQ is the
concentration of quencher [8].
The Stern–Volmer curve would be linear if the quenching
type is single static or dynamic quenching and it is an upward
curvature [12,16] if the quenching type is combined quench-
ing (both static and dynamic).
A linear Stern–Volmer plot, however, does not deﬁne the
quenching type. One of the ways to distinguish dynamic from
static quenching is to examine temperature's effect on
quenching constant Ksv. The Ksv values will be enhanced
with an increase in temperature for dynamic quenching, but
the reverse effect would be observed for static quenching [12].
The Stern–Volmer quenching constant Ksv and relative
coefﬁcients at three temperatures are listed in Table 5. The
linearity of F0/F versus cEP revealed that the quenching type
was single, static or dynamic.
Table 5 shows that the values of Ksv were enhanced when
increasing temperature, indicating that the possible
Table 2 Tolerance limits of interfering substances.
Tested substances Tested substances to analyte ratio (w/w) Tested substances Tested substances to analyte ratio (w/w)
Ethanol Over 8000 Mn2+ 1
Glucose 2500 Al3+ 0.9
Sucrose 1500 Pb2+ 0.5
Lactose 1000 Zn2+ 0.5
Na+ 150 Co2+ 0.2
Citric acid 62.5 Fe3+ 0.1
Mg2+ 5 Cu2+ 0.1
Ca2+ 5
Table 3 Comparison of methods for the determination of EP.
Technique Linearity range (µg/mL) LOD (μg/mL) Recovery (%) Reference
HPLC+SPEa 0.001–0.5 0.0025 90.272.96 [3]
HPLC 0.5–20 – 98.3 [4]
Fluorescence 0.0–40.0 0.28 95.0–102.5 [8]
Fluorescence 0.4–12.0 0.008 98.3–101.2 This work
aSPE: solid phase exteaction.
Table 4 The determination of EP in real sample and recovery.a
Sample EP added (μg/mL) EP found (μg/mL) Recovery (%) RSD (%)
EP tablets 4.00 4.05 101.2 0.38
8.00 7.86 98.2 0.43
12.00 11.80 98.3 0.58
Serum 0.00 ND – –
4.00 4.28 107.0 1.0
8.00 8.40 105.1 1.8
12.00 12.55 104.6 2.2
Urine 0.00 ND – –
4.00 4.30 107.5 1.5
8.00 8.28 103.5 1.8
12.00 12.40 103.3 2.0
ND: Not detected.
aAverage value of three determinations.
Table 5 Stern–Volmer quenching constant Ksv and correla-
tion coefﬁcients (R).
T (K) Ksv 10−4 (L/mol) R
286.15 3.4270.25 0.992
293.15 3.5770.18 0.996
303.15 3.6170.20 0.995
Determination of epristeride by its quenching effect on the ﬂuorescence of L-tryptophan 419ﬂuorescence quenching mechanism of L-tryptophan by EP
was a dynamic quenching procedure.2. The UV absorption spectra of ﬂuorescence substance in the
presence of quencher
For dynamic quenching, the absorption spectra of ﬂuores-
cence substance are not changed [8,17]. The UV absorption
spectra of 4.0 μg/mL of L-tryptophan with or without EP were
recorded under pH¼9.0 (Fig. 6).The examination demonstrated that there was almost no
difference between the absorption spectra of L-tryptophan and that
of L-tryptophan–EP mixture. From this, it can be deduced that the
ﬂuorescence quenching type of L-tryptophan initiated by EP is
dynamic quenching.
3.8.2. Synchronous ﬂuorescence spectra
The synchronous ﬂuorescence spectra give the information on
the molecular microenvironment, particularly in the vicinity of the
ﬂuorophore functional groups [18]. Therefore, the synchronous
ﬂuorescence spectra of L-tryptophan were measured at Δλ¼
80 nm (Fig. 7). As shown in Fig. 7, the position of the maxi-
mum wavelength produced a red shift, which indicates that
the microenvironment of L-tryptophan system was affected
by EP.
3.8.3. Relative ﬂuorescence quantum yield
The ﬂuorescence quantum yield Φf of L-tryptophan with or without
8.0 μg/mL EP was determined, and the Φf was 0.49 and 0.34,
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Fig. 7 Synchronous ﬂuorescence spectra of L-tryptophan at Δλ¼80
nm. 1–7: cL-tryptophan¼4.0 μg/mL, cEP¼2.0, 4.0, 8.0, 12.0, 16.0,
20.0 μg/mL.
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Fig. 6 Effect of EP on UV absorption spectrum of L-tryptophan. cL-
tryptophan: 4.0 μg/mL, cEP: 8.0 μg/mL.
A.-Q Gong, X.-S. Zhu420respectively. The results showed that the quantum yield Φf was
approximately 30% times lower in the presence of EP than that in
the absence of EP. The Φf value is closely related to chemical
structure and microenvironment of the system. The drop of Φf
indicated that in the presence of EP, the microenvironment of the
system was changed and the excited-state L-tryptophan molecules
collided with EP, so the energy of excited-state L-tryptophan
molecules was transferred to EP molecules and the quantum
yield fell.4. Conclusion
A new ﬂuorimetric method was developed and validated for the
determination of EP in human serum, urine and EP tablets. The
obtained results of interference examination showed that the
common substances from dosage forms and biological samples
did not affect the determination of EP. The biological signiﬁcance
of this work is evident since L-tryptophan is one of the necessary
amino acids and the interaction of EP and L-tryptophan has not
been characterized so far. Hence, the report has a great signiﬁcance
in pharmacology and clinical medicine as well as methodology.Acknowledgments
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